Jennifer W. Tidey Publication List 09/15/11
|
|
- Herbert Blair
- 5 years ago
- Views:
Transcription
1 PUBLICATIONS LIST ORIGINAL PUBLICATIONS IN PEER-REVIEWED JOURNALS 1. Miczek KA, Haney M, Tidey J, Vatne T, Weerts E, DeBold JF (1989). Temporal and sequential patterns of agonistic behavior: Effects of alcohol, anxiolytics and psychomotor stimulants. Psychopharmacology, 97, Tidey JW, Miczek KA (1992). Heightened aggressive behavior during morphine withdrawal: Effects of d-amphetamine. Psychopharmacology, 107, Tidey JW, Miczek KA (1992). Morphine withdrawal aggression: Modification with D1 and D2 receptor agonists. Psychopharmacology, 108, Tidey JW, Miczek KA (1992). Effects of SKF and quinpirole on aggressive, motor and schedule-controlled behaviors in mice. Behavioral Pharmacology, 3, Miczek KA, Haney M, Weerts EM, Tidey JW (1994). Neurobiological mechanisms controlling aggression: Preclinical developments for pharmacotherapeutic interventions. Neuroscience and Behavioral Reviews, 18, Tidey JW, Miczek KA (1996). Social defeat stress selectively alters mesocorticolimbic dopamine release: An in vivo microdialysis study. Brain Research, 721, Tidey JW, Miczek KA (1997). Acquisition of cocaine self-administration after social stress: Role of accumbens dopamine. Psychopharmacology, 130, Roll JM, Higgins ST, Tidey JW (1997). Cocaine use can increase cigarette smoking: Evidence from laboratory and naturalistic settings. Experimental and Clinical Psychopharmacology, 5, Tidey JW, Mehl-Madrona L, Higgins ST, Badger G (1998). Psychiatric symptom severity in cocaine-dependent outpatients: Relationships among demographics, drug use characteristics, and treatment outcome. Drug and Alcohol Dependence, 50, Tidey JW, Bergman J (1998). Drug discrimination in methamphetamine-trained monkeys: Agonist and antagonist effects of dopaminergic drugs. Journal of Pharmacology and Experimental Therapeutics, 285, Tidey JW, Higgins ST, Bickel WK, Steingard S (1999). Effects of response requirement and the presence of an alternative reinforcer on cigarette smoking by schizophrenics. Psychopharmacology, 145, Tidey JW, O Neill SC, Higgins ST (1999). Effects of abstinence on cigarette smoking among schizophrenic outpatients. Experimental and Clinical Psychopharmacology, 7, Tidey JW, O Neill SC, Higgins ST (2000). d-amphetamine increases choice of cigarette smoking over monetary reinforcement. Psychopharmacology, 153, Tidey JW, O Neill SC, Higgins ST (2002) Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental and Clinical Psychopharmacology, 10, Heil SH, Tidey JW, Holmes HW, Higgins ST, Badger GJ (2003). A contingent payment model of smoking cessation: Effects on abstinence and withdrawal. Nicotine & Tobacco Research, 5,
2 16. Sigmon SC, Tidey JW, Badger GJ, Higgins ST (2003). Acute effects of d-amphetamine on progressive-ratio performance maintained by cigarette smoking and money. Psychopharmacology, 167, Monti PM, Tidey J, Czachowski, CL, Grant KA, Rohsenow DJ, Sayette M, Manners N, Pierre, P (2004). Building bridges: The transdisciplinary study of craving from the animal lab to the lamppost. Alcoholism: Clinical and Experimental Research, 26, Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. (2005). Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug and Alcohol Dependence, 80, Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. (2005) Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine & Tobacco Research, 7, McGeary JE, Monti PM, Rohsenow DJ, Tidey JW, Swift RM, Miranda R, Jr. (2006). Genetic moderators of naltrexone s effects on alcohol cue reactivity. Alcoholism: Clinical and Experimental Research, 30, Tevyaw TO, Gwaltney C, Tidey JW, Colby SM, Kahler CW, Miranda R, Barnett NP, Rohsenow DJ, Monti PM (2007). Contingency management for adolescent smokers: An exploratory study. Journal of Child and Adolescent Substance Abuse, 16(4), Miranda Jr. R, Rohsenow DJ, Monti PM, Tidey JW, Ray R (2007). Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. Addictive Behaviors, 33(2), PMC Tidey JW, Williams JM (2007) Clinical indices of tobacco use among people with schizophrenia. Journal of Dual Diagnosis, 3 (3-4), Tidey JW, Monti P, Rohsenow D, Gwaltney C, Miranda R, McGeary J, MacKillop J, Swift, R, Abrams, D, Shiffman S, Paty J. (2008). Moderators of naltrexone s effects on drinking, urge and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcoholism: Clinical and Experimental Research, 32(1), PMC Miranda Jr., R, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J. (2008). Effects of topiramate on urge to drink and the subjective effects of alcohol consumption: A preliminary laboratory study. Alcoholism: Clinical and Experimental Research, 32(3), Tidey JW, Rohsenow DJ, Swift RM, Kaplan, GB, Adolfo, AB. (2008) Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine & Tobacco Research, 10(6), PMC Rohsenow DJ, Tidey JW, Miranda R, McGeary J, Swift R, Hutchison K, Sirota A, Monti PM. (2008). Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Experimental and Clinical Psychopharmacology, 16(3), MacKillop, J., Murphy J, Tidey J, Kahler C, Ray L, & Bickel W (2009). Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology, 203, PMC Adolfo AB*, AhnAllen C*, Tidey J (2009). Smoking cues increase urge to consume caffeinated beverages in smokers with schizophrenia. Schizophrenia Research, 107, PMC * author was a trainee 2
3 30. Tidey JW, Rohsenow DJ. (2009). Intention to quit moderates the effects of bupropion on smoking urge. Nicotine & Tobacco Research, 11(3), PMC Tevyaw T, Colby SM, Tidey JW, Kahler C, Rohsenow DJ, Barnett NP, Gwaltney CG, Monti PM (2009). Contingency management and motivational enhancement: A randomized clinical trial for college student smokers. Nicotine & Tobacco Research, 11(6), PMC Ray LA, Miranda RM, MacKillop J, McGeary JE, Tidey JW, Rohsenow, DJ, Gwaltney C, Swift RM, Monti PM (2009). A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Experimental and Clinical Psychopharmacology, 17(2): PMC in process. 33. Tidey JW, Rohsenow DJ (2009). Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls. Schizophrenia Research, 115, PMC MacKillop J, Miranda RM, Monti PM, Ray LA, Murphy JG, Rohsenow DJ, McGeary JG, Swift RM, Tidey JW, Gwaltney CJ (2010). Alcohol demand, delayed reward discounting, and mediation by craving in individuals with alcohol use disorders. Journal of Abnormal Psychology, 119(1): PMC Ray LA, Miranda RM, Tidey JW, McGeary, JE, MacKillop J, Gwaltney CJ, Rohsenow, DJ, Swift RM, Monti, PM (2010). Polymorphisms of the μ-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. Journal of Abnormal Psychology, 119(1): PMC in process. 36. Sirota AD, Rohsenow DJ, MacKinnon SV, Martin RA, Eaton CA, Kaplan GB, Monti PM, Tidey J, Swift RS (2010). Intolerance for smoking abstinence, physical and emotional discomfort questionnaires: Psychometric properties and relationship to tobacco dependence and abstinence. Addictive Behaviors, 35(7), PMC in process. 37. MacKillop J, O Hagen S, Lisman SA, Murphy JG, Ray L, McGeary JE, Tidey JW, Monti PM (2010). Behavioral economic analysis of cue-elicited craving for alcohol. Addiction, 105(9), PMC in process. 38. Murphy JG, MacKillop J, Tidey JW, Brazil LA, Colby SM (2010). Validity of a demand curve measure of nicotine reinforcement with adolescent smokers. Drug and Alcohol Dependence, 113, PMC in process. 39. MacKillop J, Tidey JW (2011). Cigarette demand and delayed reward discounting in nicotine dependent individuals with schizophrenia and controls: An initial study. Psychopharmacology. 216, PMC in process. 40. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N (2011). Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology, 217, PMC in process. 41. AhnAllen CG*, Tidey JW (2011). Personalized smoking environment cue effects in smokers with schizophrenia and controls: A pilot study. Psychiatry Research, 188, PMC in process. * author was a trainee 42. Barnett NP, Tidey J, Murphy J, Swift R, Colby SM. (2011). Contingency management for alcohol use reduction: A pilot study using a transdermal alcohol sensor. Drug and Alcohol Dependence, 2011 Jun 10. [Epub ahead of print]. PMC in process. 3
4 BOOKS AND BOOK CHAPTERS 1. Miczek KA, Tidey JW (1989). Amphetamines: aggressive and social behavior. In: Asghar K, DeSouza E (Eds.), Pharmacology and Toxicology of Amphetamine and Related Designer Drugs. National Institute on Drug Abuse Research Monograph, Washington, D. C.: U.S. Government Printing Office, Miczek KA, Haney M, Tidey JW, Vivian JA, Weerts EM (1994). Neurochemistry and pharmacotherapeutic management of aggression. In: Reis A, Roth J (Eds.), Understanding and Preventing Violence. Volume 2: Biobehavioral Influences. Washington D. C.: National Academy of Science Press, Miczek KA, DeBold JF, Haney M, Tidey JW, Vivian JA, Weerts EM (1994). Alcohol, drugs of abuse, aggression and violence. In: Reis A, Roth J (Eds.), Understanding and Preventing Violence. Volume 3: Social Influences. Washington, D. C.: National Academy of Science Press, Higgins ST, Tidey JW, Stitzer ML (1998). Community reinforcement and contingency management interventions. In: Graham AW, Schultz TK (Eds.), ASAM Principles of Addiction Medicine, 2nd edition. Chevy Chase, MD: American Society of Addiction Medicine, Higgins ST, Roll JM, Wong CJ, Tidey JW, Dantona R (1999). Clinic and laboratory studies on the use of incentives to decrease cocaine and other substance use. In: Higgins ST, Silverman K (Eds.), Motivating behavior change among illicit-drug abusers: contemporary research on contingency-management interventions. Washington, D.C.: American Psychological Association. 6. Higgins ST, Tidey JW (2003). Community reinforcement and contingency management interventions. In: Graham AW, Schultz TK, Mayo-Smith M, Ries R, Wilford B (Eds.), ASAM Principles of Addiction Medicine, 3rd edition. Chevy Chase, MD: American Society of Addiction Medicine. 7. Tidey JW, Ries R (2008). Contingency management of substance abuse in people with major mental illness. In: Higgins S, Silverman K, Heil S (Eds.), Contingency Management in Substance Abuse Treatment. New York: Guilford Press. 8. Higgins ST, Tidey JW, Rogers, RE (2009). Contingency management and the community reinforcement approach. In: Ries R, Fiellin D, Miller S, Saitz R, (Eds.), ASAM Principles of Addiction Medicine, 4th edition. Philadelphia, PA: Lippincott Williams & Wilkins. 9. Higgins ST, Tidey JW, Rogers, RE (2011). Contingency management and the community reinforcement approach. In: Cavacuite, C (Ed), Essentials of Addiction Medicine. Philadelphia, PA: Lippincott Williams & Wilkins. NON-PEER REVIEWED PUBLICATIONS 1. Tidey JW (2004) Contingency management interventions: Enhancing motivation through incentives. Brown University Digest of Addiction Theory and Application, 23, Colby S, Donny E, Tidey J (2006). Highlights from SRNT s 12th annual meeting. Society for Research on Nicotine and Tobacco Newsletter, 12(1), Donny EC, Colby SM, Tidey JW (2007). Recent progress in nicotine and tobacco research. Nicotine and Tobacco Research, 9, S PMID:
5 4. Tidey JW (in press). Commentary on Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull Jul;37(4): (Invited commentary). Evidence Based Mental Health. 5
Curriculum Vitae. Positions Held
Curriculum Vitae Name: Chad J. Gwaltney Business Address: Center for Alcohol and Addiction Studies Brown University Box G-BH Providence, RI 02912 Business Phone: (401) 444-1897 E-mail: chad_gwaltney@brown.edu
More informationDAMARIS J. ROHSENOW, PH.D.
DAMARIS J. ROHSENOW, PH.D. PERSONAL DATA Birthplace: Cambridge, Massachusetts, USA EDUCATION Ph.D., University of Washington, Seattle, WA, Clinical Psychology, 1977. B.A., University of Washington, Seattle,
More informationDanielle R. Davis. PhD, General/Experimental Psychology (Expected: May 2019) Graduate Advisor: Stephen T. Higgins, PhD
Danielle R. Davis ADDRESS: University Health Center MS #482 1 South Prospect Street Burlington, VT 05401 TEL: (802) 656-1984 or (678) 983-1253 EMAIL: ddavis4@uvm.edu EDUCATION University of Vermont (July
More informationCURRICULUM VITAE RACHEL N. CASSIDY, PH.D.
CURRICULUM VITAE RACHEL N. CASSIDY, PH.D. Assistant Professor (Research) Center for Alcohol & Addiction Studies Phone: (401) 863-6621 Brown University Fax: (401) 863-6647 BOX G-S121-4 Email: Rachel_cassidy@brown.edu
More informationDoctor of Philosophy, Clinical Psychology University at Buffalo Master or Arts, Psychology University at Buffalo 2011
Jessica D. Rhodes, Ph.D. Hoyt Science Resources Center, Rm 134 319 South Market Street New Wilmington, PA 16172 (724) 946.6240 rhodesjd@westminster.edu Education Doctor of Philosophy, Clinical Psychology
More informationEffects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results
Psychopharmacology (1999) 142 : 139 143 Springer-Verlag 1999 ORIGINAL INVESTIGATION Kent E. Hutchison Peter M. Monti Damaris J. Rohsenow Robert M. Swift Suzanne M. Colby Maryann Gnys Raymond S. Niaura
More informationCHAPTER 27: BEHAVIOR ANALYSIS AND TREATMENT OF DRUG ADDICTION
CHAPTER 27: BEHAVIOR ANALYSIS AND TREATMENT OF DRUG ADDICTION Fisher ch.27 Drug addiction is a very prevalent issue in the current United States society. The substance abuse treatments that are available
More informationDanielle R. Davis. Georgia College 2014 BS, Psychological Science
Danielle R. Davis ADDRESS: University Health Center MS #482 1 South Prospect Street Burlington, VT 05401 TEL: (802) 656-1984 or (678) 983-1253 EMAIL: ddavis4@uvm.edu EDUCATION University of Vermont MA,
More information14. Read, J. P., Brown, R. A., Marcus, B. H., Kahler, C. W., Ramsey, S. E., Dubreuil, M. E., Jakicic, J. J., & Francione, C. (2001).
PUBLICATIONS LIST ORIGINAL PUBLICATIONS IN PEER-REVIEWED JOURNALS 1. Kahler, C. W., Epstein, E. E., & McCrady, B. S. (1995). Loss of control and inability to abstain: The measurement of and the relationship
More informationBrief Intervention (BI) for Adolescents
Brief Intervention (BI) for Adolescents Sharon Levy, MD, MPH Director, Adolescent Substance Abuse Program Boston Children s Hospital Associate Professor of Pediatrics Harvard Medical School What is BI?
More informationCURRICULUM VITAE SUZANNE M. COLBY, Ph.D.
CURRICULUM VITAE SUZANNE M. COLBY, Ph.D. Business Address: Brown University Center for Alcohol and Addiction Studies Box G-S121-4 Providence, Rhode Island 02912 Office Telephone: (401) 863-6655 Business
More informationCURRICULUM VITAE July, 2011
CURRICULUM VITAE July, 2011 Stephen T. Higgins, Ph.D. Center for Substance Abuse Research & Treatment Department of Psychiatry University of Vermont 1 South Prospect Street Phone: (802) 656-9615 UHC-Campus,
More informationBehavioral Therapies for Methamphetamine Use
Behavioral Therapies for Methamphetamine Use Will M. Aklin, PhD National Institute on Drug Abuse Division of Therapeutics and Medical Consequences June 27, 2017 1 Behavioral Therapy Development Program
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationUpdate on Medications for Tobacco Cessation
Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction
More informationIsolating behavioural economic indices of demand in relation to nicotine dependence. Henry W. Chase, James MacKillop & Lee Hogarth. Psychopharmacology
Isolating behavioural economic indices of demand in relation to nicotine dependence Henry W. Chase, James MacKillop & Lee Hogarth ISSN 0033-3158 DOI 10.1007/s00213-012-2911-x 1 23 Your article is protected
More informationOlanzapine Reduces Urge to Smoke and Nicotine Withdrawal Symptoms in Community Smokers
Experimental and Clinical Psychopharmacology Copyright 2008 by the American Psychological Association 2008, Vol. 16, No. 3, 215 222 1064-1297/08/$12.00 DOI: 10.1037/1064-1297.16.3.215 Olanzapine Reduces
More informationCURRICULUM VITAE. JANE METRIK, Ph.D.
CURRICULUM VITAE JANE METRIK, Ph.D. January 2018 Address: Center for Alcohol and Addictions Studies Brown University G-S121-4 Providence, RI 02912 Telephone: (401) 863-6650 Fax: (401) 863-6647 Electronic
More informationCigarettes and Other Nicotine Products
Cigarettes and Other Nicotine Products Nicotine is one of the most heavily used addictive drugs in the United States. In 2002, 30 percent of the U.S. population 12 and older 71.5 million people used tobacco
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationNIH Public Access Author Manuscript Addict Behav. Author manuscript; available in PMC 2014 March 01.
NIH Public Access Author Manuscript Published in final edited form as: Addict Behav. 2013 March ; 38(3): 1840 1843. doi:10.1016/j.addbeh.2012.09.010. Cue-induced cigarette and food craving: A common effect?
More informationCURRICULUM VITAE. Stephen T. Higgins, Ph.D.
CURRICULUM VITAE Stephen T. Higgins, Ph.D. Director, Vermont Center for Behavior and Health Professor and Virginia H. Donaldson Chair in Translational Science University of Vermont College of Medicine
More informationUniversity of Georgia, College of Education, Athens, GA Master of Education, 1996
Curriculum Vitae ROBERT MIRANDA JR., Ph.D. Department of Psychiatry and Human Behavior Center for Alcohol and Addiction Studies Brown University Box G-S121-5 Providence, Rhode Island 02912 PH: 401.863.6658
More informationCRAVING HAS LONG BEEN CONSIDERED central
150 JOURNAL OF STUDIES ON ALCOHOL AND DRUGS / JANUARY 2010 A Principal Components Analysis of the Abbreviated Desires for Alcohol Questionnaire (DAQ)* JOHN R. KRAMER, PH.D., GRACE CHAN, PH.D., VICTOR M.
More informationPractical ways of reducing cigarette cravings. Robert West Cancer Research UK and UCL UK National Smoking Cessation Conference June 2005
Practical ways of reducing cigarette cravings Robert West Cancer Research UK and UCL UK National Smoking Cessation Conference June 2005 Outline What are cravings? The role of cravings in addiction What
More informationMedication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.
Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation
More informationTRI science. addiction
Effective Use of Rewards & Sanctions Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania Basic Terminology SANCTION REWARD GIVE Punishment Positive Reinforcement
More informationPharmacotherapy for Substance Use Disorders
Pharmacotherapy for Substance Use Disorders Vanessa de la Cruz, MD Chief of Psychiatry Mental Health and Substance Abuse Services Santa Cruz County Health Services Agency 1400 Emeline Avenue Santa Cruz,
More informationThe future of pharmacological treatment.
The future of pharmacological treatment. Anne Lingford-Hughes Professor of Addiction Biology, Imperial College. Hon Consultant CNWL NHS Foundation Trust. What substances and when? What Nicotine Alcohol
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationTobacco Addiction. Addiction Terminology. Jack E. Henningfield, PhD Johns Hopkins School of Medicine Pinney Associates
Tobacco Addiction Jack E. Henningfield, PhD Johns Hopkins School of Medicine Pinney Associates Addiction Terminology Addiction: common term applied to maladaptive drug-seeking behavior Equivalent to American
More informationUniversity of Georgia, College of Education, Athens, GA Master of Education, 1996
Curriculum Vitae ROBERT MIRANDA JR., Ph.D. Department of Psychiatry and Human Behavior Center for Alcohol and Addiction Studies Brown University Box G-S121-5 Providence, Rhode Island 02912 PH: 401.863.6658
More informationUnderstanding the Impact of Cigarette Smoking Using Brain Imaging
Understanding the Impact of Cigarette Smoking Using Brain Imaging Angelica Morales, PhD Postdoctoral Fellow Developmental Brain Imaging Lab Oregon Health & Science University No Financial Disclosures The
More informationRelationship Between Stress and Substance Use Disorders: Neurobiologic Interface
Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface Kathleen Brady, M.D., Ph.D. Professor of Psychiatry Associate Dean of Clinical and Translational Research Medical University
More informationCURRICULUM VITAE ELIZABETH R. ASTON, PH.D.
CURRICULUM VITAE ELIZABETH R. ASTON, PH.D. July 2, 2018 Address: Center for Alcohol and Addiction Studies Department of Behavioral & Social Sciences Brown University School of Public Health G-S121-5 Providence,
More informationTreatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders
University of Kentucky From the SelectedWorks of Chizimuzo T.C. Okoli December, 2010 Treatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders Chizimuzo T.C.
More information^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs
^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs wm, ROBERT M.JULIEN M.D.. PH.D. Claire D. Advokat, Ph.D. Louisiana State University and Joseph
More informationPharmacotherapy of Substance Use Disorders in Children and Adolescents: Special Considerations
Pharmacotherapy of Substance Use Disorders in Children and Adolescents: Special Considerations Dr. Ajeet Sidana Department of Psychiatry Government Medical College & Hospital Chandigarh Scope of Presentation
More informationPHARMACOTHERAPY OF SMOKING CESSATION
PHARMACOTHERAPY OF SMOKING CESSATION Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure
More informationBIOGRAPHICAL ACADEMIC POSITIONS RESEARCH POSITIONS
Curriculum Vitae JOSHUA LEE KARELITZ BIOGRAPHICAL Address: 3811 O Hara Street E-mail: jlk146@pitt.edu WPIC Room E-1343 Telephone (office): 412-246-5396 Pittsburgh, PA 15213 Telephone (fax): 412-586-9838
More informationEVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationTobacco treatment for people with serious mental illness (SMI)
Tobacco treatment for people with serious mental illness (SMI) An opportunity to close the mortality gap Massachusetts Mental Health Center 1 National Resource Center for Academic Detailing A compelling
More informationAn Evolving Perspective on Smoking Cessation Therapies
An Evolving Perspective on Smoking Cessation Therapies Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe,
More informationListen & Hear 4Lo
Mark Lim M.D FASAM Medical Director NorthLakes Community Clinic Recovery Program Board Certified in Family Medicine Board Certified in Addiction Medicine mlim@northlakesclinic.org 7156852200 Listen & Hear
More informationVarenicline and Other Pharmacotherapies for Tobacco Dependence
Varenicline and Other Pharmacotherapies for Tobacco Dependence J. Taylor Hays, M.D. Associate Director Nicotine Dependence Center Mayo Clinic 2012 MFMER slide-1 Learning Objectives Understand the mechanism
More informationCURRICULUM VITAE. VYGA GENOVEVA KAUFMANN
Kaufmann, VG 1 CURRICULUM VITAE VYGA GENOVEVA KAUFMANN Vyga.Kaufmann@colorado.edu EDUCATION Clinical 2008- Boston Consortium in Clinical Psychology, VA Boston Healthcare Internship 2009 System, Harvard
More information590,000 deaths can be attributed to an addictive substance in some way
Mortality and morbidity attributable to use of addictive substances in the United States. The Association of American Physicians from 1999 60 million tobacco smokers in the U.S. 14 million dependent on
More informationReliability and Validity of a Demand Curve Measure of Alcohol Reinforcement
Experimental and Clinical Psychopharmacology 2009 American Psychological Association 2009, Vol. 17, No. 6, 396 404 1064-1297/09/$12.00 DOI: 10.1037/a0017684 Reliability and Validity of a Demand Curve Measure
More informationADHD & Addictions -What We Know
ADHD & Addictions -What We Know Dr. David Teplin, Psy.D., C.Psych. 4th CADDAC Annual Conference, Toronto October 14, 2012 1 Introduction Adult ADHD commonly co-exists with several other disorders, including
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 3 Principles of CBT and relapse prevention strategies Introduction to Cognitive Behavioural Therapy Basics of pharmacological treatment Workshop
More informationRiunione Monotematica AISF 2017 Roma 5 Ottobre Management of Alcohol Use Disorders in Patients with Alcoholic Liver Disease
Riunione Monotematica AISF 2017 Roma 5 Ottobre 2017 Management of Alcohol Use Disorders in Patients with Alcoholic Liver Disease Lorenzo Leggio, M.D., Ph.D., M.Sc. Lorenzo Leggio, M.D., Ph.D., M.Sc. Il
More informationWhat are Substance Use Disorders?
What are Substance Use Disorders? Sanchit Maruti, MD Michael Goedde, MD University of Vermont Medical Center 1 Disclosures } Drs. Maruti and Goedde receive compensation as consultants to the American Academy
More informationALCOHOL SENSITIVITY AND ALCOHOL CRAVING
RAY, MESKEW-STACER, AND HUTCHISON 379 The Relationship Between Prospective Self-Rating of Alcohol Sensitivity and Craving and Experimental Results From Two Alcohol Challenge Studies* LARA A. RAY, M.A.,
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationCURRICULUM VITAE. A. Personal Information: Adam Matthew Leventhal, Ph.D.
April 12, 2011 CURRICULUM VITAE A. Personal Information: Name Adam Matthew Leventhal, Ph.D. Business Address Health Sciences Alhambra Campus Office University of Southern California 1000 South Fremont
More informationAlcoholism has been demonstrated to have a genetic component, especially among men.
Causes and Treatment of Substance-Related Disorders (Chapter 10) Familial and Genetic Influences Alcoholism has been demonstrated to have a genetic component, especially among men. Seems to be a common
More informationCURRICULUM VITAE. B.S. May 1998 Indiana University, Bloomington, IN Major: Psychology
CURRICULUM VITAE Name: Work Address: John Hustad, Ph.D. Department of Medicine Penn State Milton S. Hershey Medical Center P.O. Box 850, M.C. H034 Hershey, PA 17033 Phone: (717) 531-8161 Fax: (717) 531-7726
More informationTHE STATE OF MEDICINE IN ADDICTION RECOVERY
OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,
More information8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy
Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days
More information3/21/2015. Leonardo Andrade, Ph.D. Westfield State University
Leonardo Andrade, Ph.D. Westfield State University Evidence based behavioral treatment for drug abuse Theoretical foundation of CM is based on operant conditioning principles Contingencies associated with
More informationMotivational enhancement therapy for high-risk adolescent smokers
Addictive Behaviors 32 (2007) 2404 2410 Short communication Motivational enhancement therapy for high-risk adolescent smokers Amy Helstrom a,, Kent Hutchison b, Angela Bryan b a VA Boston Healthcare System,
More informationSMOKING CESSATION IS HARD
POWER TO BREAK THE HOLD OF NICOTINE ADDICTION 1 SMOKING CESSATION IS HARD Most smokers try to quit 5-7 times before they are successful. 2 Why is it so hard to quit? Typical withdrawal symptoms from stopping
More informationAddiction Medicine: What s new for primary care
Addiction Medicine: What s new for primary care Dan Vinson, MD Family and Community Medicine How to talk so our patients listen, and listen so our patients talk. 1 2 Comfortably engaging your patient in
More informationTobacco Dependence in Youths Les jeunes et la dépendance au tabac. Joseph R. DiFranza, M.D. University of Massachusetts Medical School
Tobacco Dependence in Youths Les jeunes et la dépendance au tabac Joseph R. DiFranza, M.D. University of Massachusetts Medical School Presented at the 9 th Annual Public Health Day Québec The DANDY Study
More informationNational Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says
National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:
More informationBackground. Abstinence rates associated with varenicline
What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background
More informationMedical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine
Medical Interventions for Addiction in Primary Care Settings R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine March 23, 2010 NIH Consensus on Drug Treatment Drug Addiction
More informationOpioid Use Disorder Treatment Initiation in Diverse Settings
Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures
More informationProject ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D.
Project ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D. High Levels Of Tobacco Use Almost twice as likely to smoke as people without disorders (36.1%
More informationCurriculum Vitae. Tracy O'Leary Tevyaw, Ph.D.
Curriculum Vitae Tracy O'Leary Tevyaw, Ph.D. Providence VA Medical Center 830 Chalkstone Avenue Providence, RI 02908 (401) 273-7100 x3617 Tracy.O Leary-Tevyaw@va.gov Tracy_O Leary@brown.edu EDUCATION UNDERGRADUATE
More informationScreening, Brief Intervention and Referral to Treatment SBIRT
Screening, Brief Intervention and Referral to Treatment SBIRT in Adolescent Primary Care Lydia A. Shrier, MD, MPH Associate Professor of Pediatrics Boston Children s Hospital Harvard Medical School Sharon
More informationIs wellbutrin good for opiate withdrawal. Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu
Search for: Search Search Is wellbutrin good for opiate withdrawal Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Consumer ratings reports for WELLBUTRIN XL. Includes 1411 patient rankings
More informationMETHADONE TO BUPRENORPHINE TRANSFERS TRANSITIONING FROM METHADONE MAINTENANCE TO BUPRENORPHINE/NALOXONE
METHADONE TO BUPRENORPHINE TRANSFERS TRANSITIONING FROM METHADONE MAINTENANCE TO BUPRENORPHINE/NALOXONE Work with methadone clinic staff to coordinate the methadone taper, with the transition to buprenorphine/naloxone:
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from
More informationLong term pharmacotherapy for Alcohol Dependence: Anti Craving agents
Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents Myth or Reality? Complete Recovery means a medication-free state True or False? Treatment of Alcoholism Assessment Motivation Alcohol
More information1. Would you prefer $54 today, or $55 in 117 days? [ ] larger reward in the specified number of days
Measure: Definition: Description: Delayed Reward Discounting (Monetary Choice Questionnaire) This measure assesses whether the participant prefers smaller immediate rewards over delayed larger rewards.
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationLara A. Ray, PhD 1 CURRICULUM VITAE
Lara A. Ray, PhD 1 CURRICULUM VITAE LARA A. RAY, PhD University of California, Los Angeles 3214 Franz Hall Los Angeles, CA 90095 Phone: 310-794-5383 Email: lararay@psych.ucla.edu ACADEMIC APPOINTMENTS
More informationNicotine Reduction: Harm Reduction not Prohibition
Nicotine Reduction: Harm Reduction not Prohibition Eric C. Donny, Ph.D. Endowed Professor, Departments of Physiology & Pharmacology and Social Sciences & Health Policy Director, Center for the Evaluation
More informationEvidence-Based Practice: Psychosocial Interventions
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio Talk Outline What is an evidence-based practice?
More informationTobacco dependence: Implications for service provision
Tobacco dependence: Implications for service provision Andy McEwen, PhD University College London & National Centre for Smoking Cessation and Training (NCSCT) Tuesday 29th January 2013 Cardiff Conflict
More informationCURRICULUM VITAE ALI M. YURASEK, Ph.D.
CURRICULUM VITAE ALI M. YURASEK, Ph.D. College of Health and Human Performance Phone: (352) 294-1065 Health Education and Behavior Department Fax: (352) 392-1909 University of Florida Email: a.yurasek@ufl.edu
More informationEffectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018
Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use Chad Morris, PhD March 7, 2018 2018 BHWP Behavioral Causes of Death in U.S. 2018 BHWP 2018 BHWP Health Disparities Population Behavioral
More informationScientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances
page 1/5 Scientific Facts on Psychoactive Drugs Tobacco, Alcohol, and Illicit Substances Source document: WHO (2004) Summary & Details: GreenFacts Context - Psychoactive drugs such as tobacco, alcohol,
More informationBrain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver
Brain Imaging studies in substance abuse Jody Tanabe, MD University of Colorado Denver NRSC January 28, 2010 Costs: Health, Crime, Productivity Costs in billions of dollars (2002) $400 $350 $400B legal
More informationManagement of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur
Management of Tobacco Dependence Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur Difficult to identify any other condition that presents such a mix of lethality, prevalence,
More information5.2 Altering Consciousness With Psychoactive Drugs LEARNING OBJECTIVES
Alvarenga, T. A., Patti, C. L., Andersen, M. L., Silva, R. H., Calzavara, M. B., Lopez, G.B., Tufik, S. (2008). Paradoxical sleep deprivation impairs acquisition, consolidation and retrieval of a discriminative
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationCHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE
CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE PRESENTED AND APPROVED: DECEMBER 7, 2012 EFFECTIVE: FALL 2013-14 Prefix & Number CHD 110 Purpose of this submission: Change course title to reflect current
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationSmoking cessation and reduction in people with chronic mental illness
Link to this article online for CPD/CME credits Smoking cessation and reduction in people with chronic mental illness Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02912, USA
More informationDisclosure 8/27/2014. Smoking and Substance Abuse in Individuals. ADHD and Drug Abuse
Smoking and Substance Abuse in Individuals with Brooke Molina, Ph.D. University of Pittsburgh Jessica Rhodes, Ph.D. University of Pittsburgh Disclosure Brooke Molina and Jessica Rhodes have no actual or
More informationDrugs and Society. Glen R. Hanson. Peter J. Venturelli. Annette E. Fleckenstein
Drugs and Society Glen R. Hanson Department of Pharmacology and Toxicology* University of Utah Salt Lake City, Utah Director of the Division of Neuroscience and Behavioral Research National Institute on
More informationCURRICULUM VITAE. JAMES G. MURPHY, Ph.D. Professor and Director of Clinical Training Licensed Psychologist, TN # 3104
CURRICULUM VITAE JAMES G. MURPHY, Ph.D. Professor and Director of Clinical Training Licensed Psychologist, TN # 3104 CONTACT INFORMATION Business Address/Phone: Department of Psychology Room 202, Psychology
More informationDependence Treatment: From Mouse to Man to Medicine. Caryn Lerman, Ph.D. Transdisciplinary Tobacco Use Research Center
Nicotine Dependence Treatment: From Mouse to Man to Medicine Caryn Lerman, Ph.D. Transdisciplinary Tobacco Use Research Center UPENN About this presentation Dr. Lerman presented this on December 1, 2009,
More informationSmoking Cessation. Hassan Sajjad Pulmonary & Critical Care
Smoking Cessation Hassan Sajjad Pulmonary & Critical Care Objectives Burden of Smoking Health Impacts of Smoking Smoking Cessation Motivational Interviewing Nicotine Replacement Therapy Bupropion Varenicline
More informationDisclosure Information I have the following financial relationships to disclose:
Gambling and Other Addictive Disorders Jon E. Grant, JD, MD, MPH Professor University of Chicago Disclosure Information I have the following financial relationships to disclose: My research is supported
More informationBrief Intervention for Smoking Cessation. National Training Programme
Brief Intervention for Smoking Cessation National Training Programme Introduction Monitor tobacco use and prevention policies Protect people from tobacco smoke Offer help to quit tobacco use Warn about
More information